<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>思齐俱乐部 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-02T20:29:50+08:00</updated>
  <subtitle>思齐是由一群志同道合的医药经理人在2012年初创办，打造了行业内唯一的知识分享平台（网址：www.siqiquan.org），这里有新闻资讯、视频课程、行业活动...有专业有乐趣，尽在思齐！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>备案制后，药企都开始这么布局了</title>
    <updated>2020-12-02T18:26:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/A9FswQpeCgZjUBWUrD93pw</id>
    <link href="https://mp.weixin.qq.com/s/A9FswQpeCgZjUBWUrD93pw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>12月，药企动作不断 ，透露了什么？</title>
    <updated>2020-12-02T18:26:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/P6oZVfduUhcDnE9xf9zrag</id>
    <link href="https://mp.weixin.qq.com/s/P6oZVfduUhcDnE9xf9zrag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球TOP20药企Q3市值，仅一半实现正增长！</title>
    <updated>2020-12-02T18:26:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/9of_aPHqWdiZpXw6pXIpag</id>
    <link href="https://mp.weixin.qq.com/s/9of_aPHqWdiZpXw6pXIpag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>超低价？第四批国采的“刀”或许会温和些</title>
    <updated>2020-12-01T18:31:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/pwOewWXqQQiVecyklU-tuw</id>
    <link href="https://mp.weixin.qq.com/s/pwOewWXqQQiVecyklU-tuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>知名药企组织架构重大调整，赔偿标准流出......</title>
    <updated>2020-12-01T18:31:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/isuekJp5YHvAtBzbGHLyzA</id>
    <link href="https://mp.weixin.qq.com/s/isuekJp5YHvAtBzbGHLyzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中成药集采，医保局给出回复！</title>
    <updated>2020-12-01T18:31:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/xYZAYv16rMlplolOqOMvTA</id>
    <link href="https://mp.weixin.qq.com/s/xYZAYv16rMlplolOqOMvTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年的市场预算，如何漂亮地“抢到”？</title>
    <updated>2020-11-30T18:24:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/khokHjsQgtfFGLq9HF1fMg</id>
    <link href="https://mp.weixin.qq.com/s/khokHjsQgtfFGLq9HF1fMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>备案制正式执行！不仅仅影响医药代表</title>
    <updated>2020-11-30T18:24:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/u4vm5Z_XPfKa6iwUE5mwtQ</id>
    <link href="https://mp.weixin.qq.com/s/u4vm5Z_XPfKa6iwUE5mwtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>71个符合第四批国采的产品名单已出！</title>
    <updated>2020-11-30T18:24:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/3K4EaDcm_PKzxNH5ihMfSA</id>
    <link href="https://mp.weixin.qq.com/s/3K4EaDcm_PKzxNH5ihMfSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>达能变革给药企带来的3点启发</title>
    <updated>2020-11-29T16:58:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/LnzKVFLaDFz2PwnSQR3hnw</id>
    <link href="https://mp.weixin.qq.com/s/LnzKVFLaDFz2PwnSQR3hnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！国家医保目录再传新消息</title>
    <updated>2020-11-29T16:58:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/svf9qqakUS1JtX_KkISFoQ</id>
    <link href="https://mp.weixin.qq.com/s/svf9qqakUS1JtX_KkISFoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这样的医学幻灯，到底赢在哪里？</title>
    <updated>2020-11-28T17:12:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/ZZcFFjpbowu8U4EFHelS6Q</id>
    <link href="https://mp.weixin.qq.com/s/ZZcFFjpbowu8U4EFHelS6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>知名药企，销售团队调整</title>
    <updated>2020-11-28T17:12:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/HbOvAwRF4rzgChZFoCvwmA</id>
    <link href="https://mp.weixin.qq.com/s/HbOvAwRF4rzgChZFoCvwmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>客户管理的三层功力，你到第几层？</title>
    <updated>2020-11-27T17:36:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/9LAK0RYLi-NvB9qaPf3qtw</id>
    <link href="https://mp.weixin.qq.com/s/9LAK0RYLi-NvB9qaPf3qtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>严守全球质量标准，赛诺菲扎根中国信心更足</title>
    <updated>2020-11-27T17:36:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/tsqVVN4OA3agimMWdd7JVQ</id>
    <link href="https://mp.weixin.qq.com/s/tsqVVN4OA3agimMWdd7JVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这些非基药，被限制使用</title>
    <updated>2020-11-27T17:36:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/-oZ1ABfXe7h0x5Jbgw4ipQ</id>
    <link href="https://mp.weixin.qq.com/s/-oZ1ABfXe7h0x5Jbgw4ipQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>31个临床急需药品，哪些能进入医保目录？</title>
    <updated>2020-11-26T17:38:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/RqT4JNMxN5gyNr5XCZJwzA</id>
    <link href="https://mp.weixin.qq.com/s/RqT4JNMxN5gyNr5XCZJwzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>字节跳动开线下诊所？！药企如何蹭“互联网+医疗”热度？</title>
    <updated>2020-11-26T17:38:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/_zSv8v1PJgZYt9R_rSznvQ</id>
    <link href="https://mp.weixin.qq.com/s/_zSv8v1PJgZYt9R_rSznvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最高降98.5%！专家1毛也没涨</title>
    <updated>2020-11-26T17:38:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/ZOeeYgkgahE6SSNCOxQZTw</id>
    <link href="https://mp.weixin.qq.com/s/ZOeeYgkgahE6SSNCOxQZTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这4个医药细分领域被看好</title>
    <updated>2020-11-25T18:38:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/dbt1IalFRxqmvrbrRg2wuA</id>
    <link href="https://mp.weixin.qq.com/s/dbt1IalFRxqmvrbrRg2wuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>